Accounting for quality improvement during the conduct of embedded pragmatic clinical trials within healthcare systems: NIH Collaboratory case studies
- PMID: 34175091
- PMCID: PMC8900087
- DOI: 10.1016/j.hjdsi.2020.100432
Accounting for quality improvement during the conduct of embedded pragmatic clinical trials within healthcare systems: NIH Collaboratory case studies
Abstract
Embedded pragmatic clinical trials (ePCTs) and quality improvement (QI) activities often occur simultaneously within healthcare systems (HCSs). Embedded PCTs within HCSs are conducted to test interventions and provide evidence that may impact public health, health system operations, and quality of care. They are larger and more broadly generalizable than QI initiatives, and may generate what is considered high-quality evidence for potential use in care and clinical practice guidelines. QI initiatives often co-occur with ePCTs and address the same high-impact health questions, and this co-occurrence may dilute or confound the ability to detect change as a result of the ePCT intervention. During the design, pilot, and conduct phases of the large-scale NIH Collaboratory Demonstration ePCTs, many QI initiatives occurred at the same time within the HCSs. Although the challenges varied across the projects, some common, generalizable strategies and solutions emerged, and we share these as case studies. KEY LESSONS: Study teams often need to monitor, adapt, and respond to QI during design and the course of the trial. Routine collaboration between ePCT researchers and health systems stakeholders throughout the trial can help ensure research and QI are optimally aligned to support high-quality patient-centered care.
Keywords: Embedded research; Healthcare systems; Pragmatic clinical trials; Quality improvement.
Copyright © 2020. Published by Elsevier Inc.
Conflict of interest statement
Declaration of competing interest
All authors have participated in (a) conception and design, or analysis and interpretation of the data; (b) drafting the article or revising it critically for important intellectual content; and (c) approval of the final version.
Figures
References
-
- Huang SS, Septimus E, Kleinman K, et al. Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial. Lancet. 2019;393:1205–1215. 10.1016/S0140-6736(18)32593-5. - DOI - PMC - PubMed
MeSH terms
Grants and funding
- UH3 AT009838/AT/NCCIH NIH HHS/United States
- UH2 AT007797/AT/NCCIH NIH HHS/United States
- UH3 CA188640/CA/NCI NIH HHS/United States
- UH3 DA047003/DA/NIDA NIH HHS/United States
- UL1 TR001863/TR/NCATS NIH HHS/United States
- UH3 DK102384/DK/NIDDK NIH HHS/United States
- UH3 MH007755/MH/NIMH NIH HHS/United States
- UH3 AT009844/AT/NCCIH NIH HHS/United States
- UH3 DK104655/DK/NIDDK NIH HHS/United States
- UH3 AR066795/AR/NIAMS NIH HHS/United States
- UH3 NS088731/NS/NINDS NIH HHS/United States
- UH3 AI113337/AI/NIAID NIH HHS/United States
- UH3 AG060626/AG/NIA NIH HHS/United States
- U24 AT009676/AT/NCCIH NIH HHS/United States
- UH3 HL144163/HL/NHLBI NIH HHS/United States